MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming
- DOI
- 10.1016/j.jconrel.2026.115223
- Published
- 2026-10
- Container
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2026.115223,
title = {MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming},
author = {Yan Xue and Xi Chen and Xingyu Jiang and Yibing Guo and Yan Huang and Zhen Wang and Yuhua Lu and Yumin Yang and Dongzhi Wang},
year = {2026},
journal = {Journal of Controlled Release},
doi = {10.1016/j.jconrel.2026.115223},
url = {https://doi.org/10.1016/j.jconrel.2026.115223}
}RIS
TY - JOUR TI - MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming AU - Yan Xue AU - Xi Chen AU - Xingyu Jiang AU - Yibing Guo AU - Yan Huang AU - Zhen Wang AU - Yuhua Lu AU - Yumin Yang AU - Dongzhi Wang PY - 2026 JO - Journal of Controlled Release DO - 10.1016/j.jconrel.2026.115223 UR - https://doi.org/10.1016/j.jconrel.2026.115223 ER -
APA
Xue, Y., Chen, X., Jiang, X., Guo, Y., Huang, Y., Wang, Z., Lu, Y., Yang, Y., & Wang, D. (2026). MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115223
Source records
- crossref · retrieved 2026-09-25T19:05:49.429Z